774 related articles for article (PubMed ID: 18200329)
1. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
[TBL] [Abstract][Full Text] [Related]
2. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
Shin DH; McCracken MS; Bendel RE; Pearlman R; Juzych MS; Hughes BA; Schulz LL; Kim C; Baek NH
Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
[TBL] [Abstract][Full Text] [Related]
3. A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
Bojić L; Mandić Z; Novak-Laus K; Sonicki Z; Karelović D
Coll Antropol; 2003 Dec; 27(2):729-34. PubMed ID: 14746165
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of latanoprost or fixed-combination latanoprost-timolol in patients switched from a combination of timolol and a nonprostaglandin medication.
Magacho L; Reis R; Shetty RK; Santos LC; Avila MP
Ophthalmology; 2006 Mar; 113(3):442-5. PubMed ID: 16458964
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
Nordmann JP; Söderström M; Rouland JF; Malecaze F
Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
[TBL] [Abstract][Full Text] [Related]
7. Timolol + latanoprost: new preparation. Last-resort eye drops.
Prescrire Int; 2003 Oct; 12(67):173-4. PubMed ID: 14619889
[TBL] [Abstract][Full Text] [Related]
8. Intraocular pressure-lowering activity of topical application of Aegle marmelos fruit extract in experimental animal models.
Agarwal R; Gupta SK; Srivastava S; Saxena R; Agrawal SS
Ophthalmic Res; 2009; 42(2):112-6. PubMed ID: 19556826
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
[TBL] [Abstract][Full Text] [Related]
10. Oculohypotensive effects of foeniculum vulgare in experimental models of glaucoma.
Agarwal R; Gupta SK; Agrawal SS; Srivastava S; Saxena R
Indian J Physiol Pharmacol; 2008; 52(1):77-83. PubMed ID: 18831355
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.
Diestelhorst M; Nordmann JP; Toris CB
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S155-61. PubMed ID: 12204713
[TBL] [Abstract][Full Text] [Related]
12. Latanoprost: new preparation. Antiglaucoma eye drops that can change the colour of the iris.
Prescrire Int; 1998 Dec; 7(38):166-8. PubMed ID: 10848045
[TBL] [Abstract][Full Text] [Related]
13. Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies.
Bayer A; Weiler W; Oeverhaus U; Skrotzki FE; Stewart WC;
J Ocul Pharmacol Ther; 2004 Dec; 20(6):470-8. PubMed ID: 15684807
[TBL] [Abstract][Full Text] [Related]
14. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
[TBL] [Abstract][Full Text] [Related]
15. Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range.
Varma R; Hwang LJ; Grunden JW; Bean GW; Sultan MB
Am J Ophthalmol; 2009 Aug; 148(2):221-6. PubMed ID: 19427617
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.
Konstas AG; Kozobolis VP; Tsironi S; Makridaki I; Efremova R; Stewart WC
Ophthalmology; 2008 Jan; 115(1):99-103. PubMed ID: 18166407
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the rate of nonresponders to latanoprost therapy.
Rossetti L; Gandolfi S; Traverso C; Montanari P; Uva M; Manni G; Carassa R; Mastropasqua L; Quaranta L; Marchini G; Ratiglia R; Orzalesi N
J Glaucoma; 2006 Jun; 15(3):238-43. PubMed ID: 16778647
[TBL] [Abstract][Full Text] [Related]
19. Intraocular pressure in rabbits by telemetry II: effects of animal handling and drugs.
Dinslage S; McLaren J; Brubaker R
Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2485-9. PubMed ID: 9804159
[TBL] [Abstract][Full Text] [Related]
20. Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
Fuwa M; Ueda K; Akaishi T; Yamashita N; Kirihara T; Shimazaki A; Mano H; Kawazu K
PLoS One; 2016; 11(7):e0158797. PubMed ID: 27383260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
